EUVIMEDEUVIMED entdecken
Crossref

Heterogeneous Palladium‐Catalyzed Trideuteromethylation and 13 C‐Trideuteromethylation of Arylboron Compounds via D 2 O as the Deuterium Source

Qiyuan Wang, Taoran Chen, Ying Tao, Qingzhu Xu, Junyi Shen, Zhengwu Liao, Jiangshuai Qiu, Xin Chen, Xiantong Yao, Yao Xie, Jie Wang, Lei Yu und 2 weitere

Angewandte Chemie · 05.11.2026

DOI: 10.1002/ange.4328281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 05.11.2026. Verfasst von Qiyuan Wang und 13 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrating the “magic methyl” effect and deuterium kinetic isotope effect, trideuteromethyl (CD 3 ) modification is a robust strategy for pharmaceutical development. Accordingly, the development of cost‐effective and practical methods to install CD 3 moieties into drug‐like molecules is highly desirable. Herein, we develop a reusable heterogeneous Pd‐catalyzed trideuteromethylation of arylboron esters, with D 2 O serving as the sole deuterium source. Methylthianthrenium salts (TT‐Me) act as key precursors, undergoing facile H/D exchange to in situ produce CD 3 synthons for efficient one‐pot cross‐coupling with arylboron esters. This protocol features outstanding functional group compatibility and an extraordinarily broad substrate applicability. It enables the trideuteromethylation of diverse biologically relevant scaffolds, as well as the modular two‐step synthesis of aryl‐CD 3 skeletons starting from commercially available aryl chlorides, phenols, anilines, and benzoic acids. It also facilely affords 13 CH 3 / 13 CD 3 dual‐labeled analogs for pharmaceutical and analytical use. Combined with C─H borylation, this one‐pot platform achieves direct trideuteromethylation of inert aryl C─H bonds, allowing divergent installation of two site‐specific CD 3 moieties into lidocaine isotopologues. Mechanistic investigations reveal a surface‐mediated heterogeneous pathway, where K 2 CO 3 dually activates TT‐Me and arylboron esters. This work offers a practical, scalable and sustainable route for constructing aryl–CD 3 isotopic architectures.

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Wang, Q., Chen, T., Tao, Y., Xu, Q., Shen, J., Liao, Z., Qiu, J., Chen, X., Yao, X., Xie, Y., Wang, J., Yu, L., Su, C., & Ou, W. (2026). Heterogeneous Palladium‐Catalyzed Trideuteromethylation and 13 C‐Trideuteromethylation of Arylboron Compounds via D 2 O as the Deuterium Source. Angewandte Chemie. https://doi.org/10.1002/ange.4328281

Vancouver

Wang Q, Chen T, Tao Y, Xu Q, Shen J, Liao Z, et al. Heterogeneous Palladium‐Catalyzed Trideuteromethylation and 13 C‐Trideuteromethylation of Arylboron Compounds via D 2 O as the Deuterium Source. Angewandte Chemie. 2026. doi:10.1002/ange.4328281

BibTeX
@article{Wang2026,
  author = {Wang, Qiyuan and Chen, Taoran and Tao, Ying and Xu, Qingzhu and Shen, Junyi and Liao, Zhengwu and Qiu, Jiangshuai and Chen, Xin and Yao, Xiantong and Xie, Yao and Wang, Jie and Yu, Lei and Su, Chenliang and Ou, Wei},
  title = {Heterogeneous Palladium‐Catalyzed Trideuteromethylation and 13 C‐Trideuteromethylation of Arylboron Compounds via D 2 O as the Deuterium Source},
  journal = {Angewandte Chemie},
  year = {2026},
  doi = {10.1002/ange.4328281}
}
Kostenlos starten →